Quick Answer
ProPhase Labs, Inc. reported Stockholders Equity of $7.35 million for fiscal year 2024.
ProPhase Labs, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $7.35M | -85.1% |
| 2023 | $49.38M | -22.4% |
| 2022 | $63.63M | +8.5% |
| 2021 | $58.63M | +455.4% |
| 2020 | $10.56M | -6.0% |
| 2019 | $11.23M | -31.9% |
| 2018 | $16.50M | -48.2% |
| 2017 | $31.85M | +434.2% |
| 2016 | $5.96M | -32.5% |
| 2015 | $8.83M | -17.6% |
| 2014 | $10.72M | -14.9% |
| 2013 | $12.60M | +10.0% |
| 2012 | $11.45M | +2.0% |
| 2011 | $11.23M | -16.6% |
| 2010 | $13.46M | -4.3% |
| 2009 | $14.06M | -20.9% |
| 2008 | $17.77M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.86M | -82.0% | -40.0% |
| June 30, 2025 | $11.44M | -74.1% | -24.4% |
| March 31, 2025 | $15.12M | -66.3% | +105.6% |
| December 31, 2024 | $7.35M | -85.1% | -80.7% |
| September 30, 2024 | $38.13M | -32.4% | -13.5% |
| June 30, 2024 | $44.08M | -25.6% | -1.8% |
| March 31, 2024 | $44.87M | -25.1% | -9.1% |
| December 31, 2023 | $49.38M | -22.4% | -12.5% |
- ProPhase Labs, Inc. showed a decrease of -85.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2024 period, ProPhase Labs, Inc.’s stockholders equity has declined by 58.6% (from $17.77 million to $7.35 million).
- The most recent figure is from ProPhase Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: